TY - JOUR
T1 - Development of Chagas cardiac manifestations among texas blood donors
AU - Garcia, Melissa N.
AU - Murray, Kristy O.
AU - Hotez, Peter J.
AU - Rossmann, Susan N.
AU - Gorchakov, Rodion
AU - Ontiveros, Alejandra
AU - Woc-Colburn, Laila
AU - Bottazzi, Maria Elena
AU - Rhodes, Charles E.
AU - Ballantyne, Christie M.
AU - Aguilar, David
N1 - Funding Information:
This study was funded by the Baylor College of Medicine Cardiovascular Research Institute .
Publisher Copyright:
© 2015 Elsevier Inc. All rights reserved.
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Chagas disease, infection with the parasite Trypanosoma cruzi, has recently been identified as an important emerging parasitic disease in the United States. To describe the cardiac abnormalities in T. cruzi-positive blood donors in southeastern Texas, a pilot study of donors who had screened positive from 2007 to 2012 was performed. This one-time assessment included (1) a questionnaire to evaluate the source of infection, cardiac symptoms, and health co-morbidities; (2) electrocardiography; (3) echocardiography if electrocardiographic findings were abnormal; and (4) measurement of a high-sensitivity troponin T biomarker. Of those with confirmed infection, 41% (7 of 17) had electrocardiographic abnormalities consistent with Chagas cardiomyopathy. In addition, 36% (6 of 17) were suspected to be locally acquired cases. High-sensitivity troponin T serum levels increased with cardiac severity. In conclusion, cardiologists should consider Chagas disease in their differential diagnoses for patients who may have clinically compatible electrocardiographic changes or nonischemic cardiomyopathy, even if the patients have no histories of residing in Chagas-endemic countries.
AB - Chagas disease, infection with the parasite Trypanosoma cruzi, has recently been identified as an important emerging parasitic disease in the United States. To describe the cardiac abnormalities in T. cruzi-positive blood donors in southeastern Texas, a pilot study of donors who had screened positive from 2007 to 2012 was performed. This one-time assessment included (1) a questionnaire to evaluate the source of infection, cardiac symptoms, and health co-morbidities; (2) electrocardiography; (3) echocardiography if electrocardiographic findings were abnormal; and (4) measurement of a high-sensitivity troponin T biomarker. Of those with confirmed infection, 41% (7 of 17) had electrocardiographic abnormalities consistent with Chagas cardiomyopathy. In addition, 36% (6 of 17) were suspected to be locally acquired cases. High-sensitivity troponin T serum levels increased with cardiac severity. In conclusion, cardiologists should consider Chagas disease in their differential diagnoses for patients who may have clinically compatible electrocardiographic changes or nonischemic cardiomyopathy, even if the patients have no histories of residing in Chagas-endemic countries.
UR - http://www.scopus.com/inward/record.url?scp=84915758745&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84915758745&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2014.09.050
DO - 10.1016/j.amjcard.2014.09.050
M3 - Article
C2 - 25456877
AN - SCOPUS:84915758745
SN - 0002-9149
VL - 115
SP - 113
EP - 117
JO - American Journal of Cardiology
JF - American Journal of Cardiology
IS - 1
ER -